Poor suitability for psychotherapy - a risk factor for treatment non-attendance?

J Affect Disord. 2021 Dec 1:295:1432-1439. doi: 10.1016/j.jad.2021.09.020. Epub 2021 Sep 17.

Abstract

Background: Patient suitability has been suggested to predict treatment non-attendance but information on its effect is limited.

Aim: To study the prediction of the Suitability for Psychotherapy Scale (SPS), on occurrence of treatment non-attendance.

Methods: Altogether 326 outpatients, with depressive or anxiety disorder, were randomized to short-term psychodynamic psychotherapy (SPP), long-term psychodynamic psychotherapy (LPP), and solution-focused therapy (SFT). SPS was based on seven components from three suitability domains: nature of problems, ego strength, and self-observing capacity. Treatment non-attendance was defined as refusal of engaging therapy and of premature termination. The Cox model and logistic regression were used.

Results: Treatment non-attendance was significantly more common in LPP patients with poor SPS (RR = 2.76, 95% CI = 1.45-5.26). This was mainly due to poor flexibility of interaction, poor self-concept, and poor reflective ability. Premature termination in SFT showed a similar trend but due to other SPS components: absence of a circumscribed problem, poor modulation of affects, and poor response to trial interpretation. On the contrary, individuals with good values of SPS were more prone to premature termination in SPP.

Limitations: The prediction of suitability on refusal could only be studied in the LPP group due to few refusals in the short-term therapy groups. The sample consisted of patients who participated in a trial. Thus the findings may not be directly generalized to unselected patients in the public mental health setting.

Conclusions: Poor suitability, apparently, predicts non-attendance in LPP and SFT, but not in SPP. More studies on large cohorts are needed.

Keywords: Non-attendance; Premature termination; Psychotherapy; Suitability; Treatment refusal.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anxiety Disorders
  • Follow-Up Studies
  • Humans
  • Mood Disorders
  • Psychotherapy
  • Psychotherapy, Brief*
  • Psychotherapy, Psychodynamic*
  • Risk Factors
  • Treatment Outcome